Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Amyotrophic Lateral Sclerosis (ALS) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amyotrophic Lateral Sclerosis (ALS) Overall Market Size
2.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size: 2021 VS 2028
2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Amyotrophic Lateral Sclerosis (ALS) Sales: 2017-2028
3 Company Landscape
3.1 Top Amyotrophic Lateral Sclerosis (ALS) Players in Global Market
3.2 Top Global Amyotrophic Lateral Sclerosis (ALS) Companies Ranked by Revenue
3.3 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Companies
3.4 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Companies
3.5 Global Amyotrophic Lateral Sclerosis (ALS) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Amyotrophic Lateral Sclerosis (ALS) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis (ALS) Players in Global Market
3.8.1 List of Global Tier 1 Amyotrophic Lateral Sclerosis (ALS) Companies
3.8.2 List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis (ALS) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Market Size Markets, 2021 & 2028
4.1.2 Riluzole
4.1.3 Edaravone (Radicava)
4.1.4 Other
4.2 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue & Forecasts
4.2.1 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2022
4.2.2 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2023-2028
4.2.3 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
4.3 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales & Forecasts
4.3.1 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2022
4.3.2 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2023-2028
4.3.3 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
4.4 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue & Forecasts
5.2.1 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2022
5.2.2 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2023-2028
5.2.3 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
5.3 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales & Forecasts
5.3.1 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2022
5.3.2 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2023-2028
5.3.3 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
5.4 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Market Size, 2021 & 2028
6.2 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue & Forecasts
6.2.1 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2022
6.2.2 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2023-2028
6.2.3 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
6.3 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales & Forecasts
6.3.1 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2022
6.3.2 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2023-2028
6.3.3 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.4.2 By Country - North America Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.4.3 US Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.4.4 Canada Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.4.5 Mexico Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.5.2 By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.5.3 Germany Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.4 France Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.5 U.K. Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.6 Italy Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.7 Russia Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.8 Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.9 Benelux Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.6.2 By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.6.3 China Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.4 Japan Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.5 South Korea Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.6 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.7 India Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.7.2 By Country - South America Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.7.3 Brazil Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.7.4 Argentina Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.8.3 Turkey Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8.4 Israel Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8.5 Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8.6 UAE Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Mitsubishi Tanabe Pharma
7.1.1 Mitsubishi Tanabe Pharma Corporate Summary
7.1.2 Mitsubishi Tanabe Pharma Business Overview
7.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.1.5 Mitsubishi Tanabe Pharma Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Mylan Pharma
7.3.1 Mylan Pharma Corporate Summary
7.3.2 Mylan Pharma Business Overview
7.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.3.5 Mylan Pharma Key News
7.4 Apotex
7.4.1 Apotex Corporate Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.4.5 Apotex Key News
7.5 Glemark Generics
7.5.1 Glemark Generics Corporate Summary
7.5.2 Glemark Generics Business Overview
7.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.5.5 Glemark Generics Key News
7.6 Covis Pharma
7.6.1 Covis Pharma Corporate Summary
7.6.2 Covis Pharma Business Overview
7.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.6.5 Covis Pharma Key News
7.7 Sun Pharma
7.7.1 Sun Pharma Corporate Summary
7.7.2 Sun Pharma Business Overview
7.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.7.5 Sun Pharma Key News
7.8 Lunan Pharma
7.8.1 Lunan Pharma Corporate Summary
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.8.5 Lunan Pharma Key News
8 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity, Analysis
8.1 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity, 2017-2028
8.2 Amyotrophic Lateral Sclerosis (ALS) Production Capacity of Key Manufacturers in Global Market
8.3 Global Amyotrophic Lateral Sclerosis (ALS) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Amyotrophic Lateral Sclerosis (ALS) Supply Chain Analysis
10.1 Amyotrophic Lateral Sclerosis (ALS) Industry Value Chain
10.2 Amyotrophic Lateral Sclerosis (ALS) Upstream Market
10.3 Amyotrophic Lateral Sclerosis (ALS) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Amyotrophic Lateral Sclerosis (ALS) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer